A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension

Author: Coleman A.L.   Lerner F.   Bernstein P.   Whitcup S.M.   Lumigan/Cosopt Study Group  

Publisher: Elsevier

ISSN: 0161-6420

Source: Ophthalmology, Vol.110, Iss.12, 2003-12, pp. : 2362-2368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content